One68 Global Capital’s Bristol-Myers Squibb BMY Stock Holding History

One68 Global Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$1.05M	Buy	+17,000	New	+$1.05M	2.12%	10

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

One68 Global Capital's BMY Position: Q4 2020 in Review

One68 Global Capital opened a new position in Bristol-Myers Squibb (BMY) in Q4 2020: 17,000 shares worth $1.05M. The stake represents 2.12% of the portfolio and ranks #10 among its holdings.

2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

One68 Global Capital held 17,000 shares of Bristol-Myers Squibb worth $1.05M as of Q4 2020.
Bristol-Myers Squibb was a new One68 Global Capital position in Q4 2020.
Bristol-Myers Squibb made up 2.12% of One68 Global Capital's portfolio in Q4 2020, its #10 holding.
2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.